Humberg, Alexander
Fortmann, Ingmar
Siller, Bastian
Kopp, Matthias Volkmar
Herting, Egbert
Göpel, Wolfgang
Härtel, Christoph
,
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01GL1746B, 01ER0805)
Bundesministerium für Bildung und Forschung (01ER1501)
Article History
Received: 22 May 2020
Accepted: 24 June 2020
First Online: 13 July 2020
Compliance with ethical standards
:
: Christoph Härtel is a lead principal investigator of the PRIMAL clinical study investigating the effect of probiotics to prevent gut dysbiosis and inflammation in preterm infants born at 28–32 weeks of gestation. All other authors have no conflicts of interest relevant to this article to disclose.